Exchanges: NASDAQ | NYSE | XLON | AMS | ADS | TSE | BRU

Financial News Feed

Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -103.28% and -60.50%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Read more

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2019 Results Earnings Conference Call May 08, 2019, 04:30 PM ET Company Participants Rajendra Ketkar - President and

Read more

NEW YORK , April 18, 2019 /PRNewswire/ -- The tremendous growth of the cannabis market is causing the marketspace to become an emerging global industry. In 2017, U.S. cannabis legal sales were between USD 5.8 Billion and USD 6.6 Billion , according to Marijuana Business Factbook. Perhaps surprisingly, the industry's market value is already comparable to major worldwide corporations such as Netflix and McDonald's. However, the market is still heavily hindered by regulatory restrictions imposed by federal governments around the world. Under international regulations, cannabis is one of the most heavily enforced drugs, primarily due to the psychoactive effects of marijuana. The marijuana plant is comprised primarily of THC, which causes the psychoactive effects. However, the cannabis plant is split into marijuana and hemp, with hemp being the non-psychoactive derivative of the cannabis plant. While the two differ in their makeup, they both offer therapeutic benefits, causing a surge in adoption for medical applications.

Read more

Stock Under Scrutiny: Arcadia Bio (RKDA)
07:19pm, Tuesday, 02'nd Apr 2019
Tracking moving averages is one of the most universally used techniques for performing technical stock analysis. Checking on some levels for Arcadia Bio (RKDA), the 50-day Moving Average is currently

Read more

The analytical study of this Global Biofortification Market report supports mapping growth strategies to boost sales and build brand image on the market. Businesses can set inventive ideas and strikin

Read more

Arcadia Biosciences, Inc. (NasdaqCM:RKDA) have seen a year over year change of sales growth of -0.63636. The 33472 market value company based out of United States of America is an important player in

Read more

Checking in on some valuation rankings, Arcadia Biosciences, Inc. (NasdaqCM:RKDA) has a Value Composite score of 97. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These

Read more

Arcadia Bio (RKDA) have climbed 98.22% higher over the course of the past quarter revealing positive directional momentum for the stock. In taking a look at recent performance, we can see that shares

Read more

The stock of Arcadia Biosciences, Inc. (NASDAQ:RKDA) is a huge mover today! The stock increased 4.94% or $0.33 during the last trading session, reaching $7.01. About 192,377 shares traded. Arcadia Bio

Read more

Arcadia Biosciences (NASDAQ:RKDA) posted its earnings results on Wednesday. The basic materials company reported ($0.14) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consen

Read more

At current levels, Arcadia Bio (RKDA) is trading below the Chikou. If the stock continues to stay under the line, traders could be projecting a possible downward momentum swing. As the next round of e

Read more

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar and CFO Matt Plavan tells Proactive Investors that the company is transitioning to a new health and nutrition business model from an old R&D-focuse

Read more

Arcadia Biosciences (NASDAQ:RKDA) announced its quarterly earnings data on Wednesday. The basic materials company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.76) by $0.

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank